logo

For the Inventor, By the Inventor

US

Vectorpharma International Corporation

Calculating rank
USPTO Granted Patents = 11


Forward Citations = 264

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Mara L Lovrecich (8 out of 9 patents)

silverMedal Fabio Carli (5 out of 13 patents)

bronzeMedal Luca Dobetti (2 out of 8 patents)

4.  Tiziana Canal (2 out of 6 patents)

5.  Giovanna Riccioni (2 out of 2 patents)

6.  Italo Colombo (1 out of 3 patents)

7.  Pierandrea Esposito (1 out of 5 patents)

8.  Leonardo Rabaglia (1 out of 2 patents)

9.  Daniela Lombardi (1 out of 1 patent)

10.  Luigi Boltri (1 out of 1 patent)

11.  Mara Lucia Lovrecich (0 patent)


11 patents:

1. 6107276 - Pharmaceutical compositions including a drug, a cross-linked polymeric (2000-08-22),
2. 5700486 - Pharmaceutical compositions in the form of particles suitable for the (1997-12-23),
3. 5582836 - Transdermal therapeutic compositions (1996-12-10),
4. 5569469 - Poorly soluble medicaments supported on polymer substances in a form (1996-10-29),
5. 5536508 - Pharmaceutical compositions in the form of particles suitable for the (1996-07-16),
6. 5354560 - Supported drugs with increased dissolution rate, and a process for their (1994-10-11),
7. 5275824 - Therapeutic compositions with controlled release of medicaments (1994-01-04),
8. 5225192 - Poorly soluble medicaments supported on polymer substances in a form (1993-07-06),
9. 5215752 - Pharmaceutical tablets and capsule granulates of scleroglucan and active (1993-06-01),
10. 5068111 - Pharmaceutical tablets and capsule granulates of scleroglucan and active (1991-11-26),
11. 5008114 - Pharmaceutical compositions with controlled release, and a method for (1991-04-16),
Company Overview
Vectorpharma International Corporation is a US-based organization specializing in the development and manufacturing of innovative pharmaceutical products. The company focuses on advanced drug delivery systems and biopharmaceuticals, leveraging cutting-edge research to enhance therapeutic efficacy. With a commitment to improving patient outcomes, Vectorpharma engages in various research domains, including formulation science and biologics, positioning itself as a key player in the global healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

11 Patents

#76 in undefined, undefined

#105 in

#27,529 in US

#51,801 in the World

US
US

Vectorpharma International Corporation

Forward Citations = 264

10 inventors:

goldMedal Mara L Lovrecich (8 out of 9 patents)

silverMedal Fabio Carli (5 out of 13 patents)

bronzeMedal Luca Dobetti (2 out of 8 patents)

4.  Tiziana Canal (2 out of 6 patents)

5.  Giovanna Riccioni (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vectorpharma International Corporation. Retrieved from https://idiyas.com/company/vectorpharma-international

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…